U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090629) titled 'THE BENEFITS OF THE MEASURE OF EPICARDIAL ADIPOSE TISSUE DURING CORONARY CALCIUM ASSESSMENT TO REFINE CARDIOVASCULAR RISK ASSESSMENT AT REUNION ISLAND' on July 21.
Brief Summary: The goal of this retrospective study is to see whether patients with familial partial type 2 lipodystrophy, who are at high cardiovascular risk present a higher volume of visceral epicardial adipose tissue than other patients without familial partial lipodystrophy who were assessed for their cardiovascular risk using coronary artery calcification scoring between 2016 and 2024.
Study Start Date: May 06, 2024
Study Type: OBSERVATIONAL
Condition:
High Chol...